Skip to main content
logo
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
961.26
+33.37 (3.60%)
At close: Nov 2, 2026, 4:00 PM EST
967.84
+6.58 (0.68%)
After-hours: Nov 2, 2026, 4:34 PM EST

Regeneron Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
16,89614,34314,20213,11712,17316,072
Revenue Growth
18.59%0.99%8.27%7.76%-24.26%89.14%
Gross Profit
7,8966,3927,1006,8627,02010,774
Operating Income
5,1343,7024,1454,2334,9948,995
Net Income
4,8174,5054,4133,9544,3388,075
Earnings Per Share
45.1741.4838.3434.7738.2271.97
EPS Growth
8.59%8.19%10.27%-9.03%-46.89%135.81%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Product Sales
6,6576,3097,6297,0786,89412,117
Total Collaboration
9,3267,3316,0585,5034,9143,673
Other Product
913.1702.6515536.1365.1281.2
Revenue (Total)
16,89614,34314,20213,11712,17316,072

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18,85918,86617,91316,24114,33412,533
Total Debt
2,7072,9732,9392,7912,7702,700
Net Cash (Debt)
16,15215,89314,97413,45111,5659,833
Net Cash Growth
0.80%6.14%11.32%16.31%17.61%144.18%
Net Cash Per Share
151.44146.35130.09118.30101.8987.64

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,8464,9794,4214,5945,0157,081
Capital Expenditures
-1,020-898.4-755.9-718.6-590.1-551.9
Free Cash Flow
3,8264,0813,6653,8754,4256,529
Free Cash Flow Growth
-9.37%11.35%-5.44%-12.42%-32.23%225.90%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.73%44.57%49.99%52.32%57.67%67.04%
Operating Margin
30.38%25.81%29.19%32.27%41.03%55.97%
Pretax Margin
33.66%36.47%33.66%32.01%39.91%58.03%
Profit Margin
28.51%31.41%31.07%30.14%35.64%50.24%
FCF Margin
22.65%28.45%25.80%29.54%36.35%40.63%

Dividends
Chart
Fiscal Year
CurrentFY 2025
Period EndingNov '26 Dec '25
Dividend Per Share
3.7603.520
Dividend Per Share Growth
6.82%-
Dividend Yield
0.39%0.46%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.2817.5817.3723.6317.768.18
Forward PE
12.2617.1115.1919.3617.2911.00
P/FCF Ratio
25.1319.4120.9124.1017.4210.11
PS Ratio
5.695.525.407.126.334.11